Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23

Section 12.2

Rules re s. 12.1

Cite as Drug Interchangeability and Dispensing Fee Act, R.S.O. 1990, c. P.23, s. 12.2 · current to November 11, 2026 · consolidated from June 3, 2016 · read from e-Laws on November 16, 2026

The text

(1) The following rules apply with regard to an order made or a notice given by the executive officer under section 12.1: 1. The order or notice must be in writing, and set out in brief the reason for which it is made. 2. An order must set out how any amount required to be paid under the order was calculated, specify any right of reconsideration that is available, and the time within which reconsideration is available. 3. In the case of an order or notice under section 12.1 that applies to a manufacturer, the order or notice may be served by leaving a copy of the document with an officer, director or agent of the manufacturer, or with an individual at any place of business of the manufacturer who appears to be in control or management of the place of business. 4. In the case of an order or notice under section 12.1 that applies to a person mentioned in subsection 12.1 (3), the order or notice may be served by leaving a copy of the document with the person if the person is an individual, or with an officer, director or agent of the person, or with an individual at any place of business of the person mentioned in subsection 12.1 (3) who appears to be in control or management of the place of business. 5. An order must specify the time period with respect to which the order is made, which may include a time period with respect to which a previous order was made, if the previous order has not been complied with. 6. An order must set out the time period in which the manufacturer or person mentioned in subsection 12.1 (3) is required to comply with the order. 7. An order must specify the consequences for failing to comply with the order. 2006, c. 14, s. 3. (2) The executive officer may publish on the Ministry’s website the corporate names of manufacturers or any other persons against whom the executive officer has taken action under section 12.1 and may also publish any information he or she considers appropriate about the action that has been taken. 2006, c. 14, s. 3. (3) There is no appeal from a decision or action of the executive officer under section 12.1, except as provided for in that section. 2006, c. 14, s. 3.
Read the Drug Interchangeability and Dispensing Fee Act on e-Laws ↗